Cyclosporin a inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation

Kei Ichi Nakayama, Hiromitsu Nakauchi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cyclosporin A (CsA) is a powerful immunosuppressive drug widely used in transplantation medicine. A major effect of CsA is inhibition of the differentiation of immature double-positive (DP) CD4+CD8+ thymocytes into mature single-positive (SP) CD4+CD8- or CD4-CD8+thymocytes. The mechanisms underlying the changes in CD4/CD8 expression during normal differentiation of thymocytes and the way CsA interferes with this differentiation process are still unknown. Here we show that protein kinase C (PKC) activation by phorbol 12-myristate 13-acetate (PMA) causes a decrease of both CD4 and CD8 expression at the cell surface level and at the mRNA level in a CD4+CD8+ T cell line and in freshly isolated thymocytes. A PKC inhibitor, staurosporin, interferes with the differentiation from DP to SP in fetal thymus organ culture system. These data suggest that the alternation of CD4/CD8 expression from DP to SP is dependent on PKC activation. CsA blocks this decrease of CD4/CD8 expression by PMA in vitro. Moreover, this PMA effect is also blocked by treatment with cycloheximlde. These results suggest that the reduction of CD4/CD8 expression requires de novo synthesis of a protein(s) induced in response to a signal conveyed by activated PKC. CsA may block the transition from DP to SP by inhibition of CD4/CD8 down-regulation induced by PKC activation.

Original languageEnglish
Pages (from-to)419-426
Number of pages8
JournalInternational Immunology
Volume5
Issue number4
DOIs
Publication statusPublished - Dec 1 1993
Externally publishedYes

Fingerprint

Protein Kinase C
Cyclosporine
Activation
Thymocytes
Chemical activation
Proteins
Decrease
Acetates
Thymus
Transplantation
Protein C Inhibitor
Transplantation (surgical)
Alternation
Organ Culture Techniques
T-cells
Protein Kinase Inhibitors
Immunosuppressive Agents
Messenger RNA
Medicine
Thymus Gland

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Cyclosporin a inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation. / Nakayama, Kei Ichi; Nakauchi, Hiromitsu.

In: International Immunology, Vol. 5, No. 4, 01.12.1993, p. 419-426.

Research output: Contribution to journalArticle

@article{302f3f4443534905bd03e29f14dfa760,
title = "Cyclosporin a inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation",
abstract = "Cyclosporin A (CsA) is a powerful immunosuppressive drug widely used in transplantation medicine. A major effect of CsA is inhibition of the differentiation of immature double-positive (DP) CD4+CD8+ thymocytes into mature single-positive (SP) CD4+CD8- or CD4-CD8+thymocytes. The mechanisms underlying the changes in CD4/CD8 expression during normal differentiation of thymocytes and the way CsA interferes with this differentiation process are still unknown. Here we show that protein kinase C (PKC) activation by phorbol 12-myristate 13-acetate (PMA) causes a decrease of both CD4 and CD8 expression at the cell surface level and at the mRNA level in a CD4+CD8+ T cell line and in freshly isolated thymocytes. A PKC inhibitor, staurosporin, interferes with the differentiation from DP to SP in fetal thymus organ culture system. These data suggest that the alternation of CD4/CD8 expression from DP to SP is dependent on PKC activation. CsA blocks this decrease of CD4/CD8 expression by PMA in vitro. Moreover, this PMA effect is also blocked by treatment with cycloheximlde. These results suggest that the reduction of CD4/CD8 expression requires de novo synthesis of a protein(s) induced in response to a signal conveyed by activated PKC. CsA may block the transition from DP to SP by inhibition of CD4/CD8 down-regulation induced by PKC activation.",
author = "Nakayama, {Kei Ichi} and Hiromitsu Nakauchi",
year = "1993",
month = "12",
day = "1",
doi = "10.1093/intimm/5.4.419",
language = "English",
volume = "5",
pages = "419--426",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Cyclosporin a inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation

AU - Nakayama, Kei Ichi

AU - Nakauchi, Hiromitsu

PY - 1993/12/1

Y1 - 1993/12/1

N2 - Cyclosporin A (CsA) is a powerful immunosuppressive drug widely used in transplantation medicine. A major effect of CsA is inhibition of the differentiation of immature double-positive (DP) CD4+CD8+ thymocytes into mature single-positive (SP) CD4+CD8- or CD4-CD8+thymocytes. The mechanisms underlying the changes in CD4/CD8 expression during normal differentiation of thymocytes and the way CsA interferes with this differentiation process are still unknown. Here we show that protein kinase C (PKC) activation by phorbol 12-myristate 13-acetate (PMA) causes a decrease of both CD4 and CD8 expression at the cell surface level and at the mRNA level in a CD4+CD8+ T cell line and in freshly isolated thymocytes. A PKC inhibitor, staurosporin, interferes with the differentiation from DP to SP in fetal thymus organ culture system. These data suggest that the alternation of CD4/CD8 expression from DP to SP is dependent on PKC activation. CsA blocks this decrease of CD4/CD8 expression by PMA in vitro. Moreover, this PMA effect is also blocked by treatment with cycloheximlde. These results suggest that the reduction of CD4/CD8 expression requires de novo synthesis of a protein(s) induced in response to a signal conveyed by activated PKC. CsA may block the transition from DP to SP by inhibition of CD4/CD8 down-regulation induced by PKC activation.

AB - Cyclosporin A (CsA) is a powerful immunosuppressive drug widely used in transplantation medicine. A major effect of CsA is inhibition of the differentiation of immature double-positive (DP) CD4+CD8+ thymocytes into mature single-positive (SP) CD4+CD8- or CD4-CD8+thymocytes. The mechanisms underlying the changes in CD4/CD8 expression during normal differentiation of thymocytes and the way CsA interferes with this differentiation process are still unknown. Here we show that protein kinase C (PKC) activation by phorbol 12-myristate 13-acetate (PMA) causes a decrease of both CD4 and CD8 expression at the cell surface level and at the mRNA level in a CD4+CD8+ T cell line and in freshly isolated thymocytes. A PKC inhibitor, staurosporin, interferes with the differentiation from DP to SP in fetal thymus organ culture system. These data suggest that the alternation of CD4/CD8 expression from DP to SP is dependent on PKC activation. CsA blocks this decrease of CD4/CD8 expression by PMA in vitro. Moreover, this PMA effect is also blocked by treatment with cycloheximlde. These results suggest that the reduction of CD4/CD8 expression requires de novo synthesis of a protein(s) induced in response to a signal conveyed by activated PKC. CsA may block the transition from DP to SP by inhibition of CD4/CD8 down-regulation induced by PKC activation.

UR - http://www.scopus.com/inward/record.url?scp=0027191899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027191899&partnerID=8YFLogxK

U2 - 10.1093/intimm/5.4.419

DO - 10.1093/intimm/5.4.419

M3 - Article

C2 - 8494827

AN - SCOPUS:0027191899

VL - 5

SP - 419

EP - 426

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 4

ER -